EMJ Oncology 9 [Supplement 6] . 2021

In this issue

During a symposium at the virtual European Society for Medical Oncology (ESMO) World Congress on Gastrointestinal Cancer 2021, Eric Van Cutsem, Angela Lamarca, Nicola Normanno, and Arndt Vogel discussed better patient identification, biomarkers, genomic testing, and emerging therapies in the context of cholangiocarcinoma (CCA). The challenges associated with precision medicine were also explored.

Rate this content's potential impact on patient outcomes

Average rating / 5. Vote count:

No votes so far! Be the first to rate this content.